TrialAmerican journal of hematology2025

Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.

Rexhep Durmo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.